MERITAGE PORTFOLIO MANAGEMENT – Halozyme Therapeutics, Inc. Transaction History
MERITAGE PORTFOLIO MANAGEMENT portfolio value:
$8.08M
portfolio value
Halozyme Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | 0.00% | 204.57K shares | 8.08M | $39.54 | 204.57K |